Cefuroxime - 25021-120-59 - (cefuroxime sodium)

Alphabetical Index


Drug Information of Cefuroxime

Product NDC: 25021-120
Proprietary Name: Cefuroxime
Non Proprietary Name: cefuroxime sodium
Active Ingredient(s): 7.5    g/82.5mL & nbsp;   cefuroxime sodium
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Cefuroxime

Product NDC: 25021-120
Labeler Name: Sagent Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA065046
Marketing Category: ANDA
Start Marketing Date: 20080501

Package Information of Cefuroxime

Package NDC: 25021-120-59
Package Description: 10 VIAL in 1 CARTON (25021-120-59) > 82.5 mL in 1 VIAL

NDC Information of Cefuroxime

NDC Code 25021-120-59
Proprietary Name Cefuroxime
Package Description 10 VIAL in 1 CARTON (25021-120-59) > 82.5 mL in 1 VIAL
Product NDC 25021-120
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name cefuroxime sodium
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20080501
Marketing Category Name ANDA
Labeler Name Sagent Pharmaceuticals
Substance Name CEFUROXIME SODIUM
Strength Number 7.5
Strength Unit g/82.5mL
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Cefuroxime


General Information